Health
Mounjaro and Zepbound: The Case for Two Hormones at Once
Tirzepatide just beat semaglutide head to head in a major trial. Here is what SURMOUNT and SURPASS data actually shows about hitting two receptors.
Dec 9, 2024
Loading
Search
Results
4 stories for“zepbound weight loss”
Nutrition
Tirzepatide Switched On Calorie-Burning Brown Fat in Obese Mice, Independent of Its Appetite-Suppressing Effect
A pair-feeding study found tirzepatide, the drug in Zepbound and Mounjaro, activated thermogenic markers in brown fat and improved glucose tolerance in obese mice even when food intake was matched to untreated animals.
Sep 29, 2026
Health
GLP-1 Drugs Are Becoming More Than Weight Loss Medicine
Tirzepatide just earned an approval that has nothing to do with the scale. Here is what SELECT, FLOW and the new sleep apnea data show.
Jan 8, 2025
Health
One Receptor, Two, or Three: Comparing Semaglutide, Tirzepatide and Retatrutide
Ozempic, Mounjaro and the drug that has not arrived yet are not three versions of the same thing. They hit different receptors, produce different results, and suit different people.
Aug 11, 2026
